Medical cannabis: What practitioners need to know

This publication has 44 references indexed in Scilit:

• Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
  Epilepsy & Behavior, 2018
• Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
  The Lancet, 2018
• Medical use of cannabis and cannabinoids containing products – Regulations in Europe and North America
  European Journal of Internal Medicine, 2018
• Cannabis induced psychosis and subsequent psychiatric disorders
  Asian Journal of Psychiatry, 2017
• Labeling Accuracy of Cannabidiol Extracts Sold Online
  JAMA, 2017
• Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting—a systematic review of systematic reviews
  Der Schmerz, 2016
• Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
  JAMA, 2015
• Cannabinoids for Medical Use
  JAMA, 2015
• The P harmacologic and C linical E ffects of M edical C annabis
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
• Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review
  Pharmacology Biochemistry and Behavior, 2008